Clinitech Laboratory SME IPO Details, Financials, Valuation & Peers
Get everything you need to know about the Clinitech Laboratory IPO. Explore Clinitech Laboratory IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Overview
Clinitech Laboratory Limited is a provider of diagnostic and healthcare tests and services, operating a chain of eight diagnostic centers located in and around Thane and Navi Mumbai. With over 30 years of experience in the diagnostic business, Clinitech conducts more than 3 Lakh tests annually in its NABL-accredited laboratories, which are equipped with modern technology and high-end equipment. The company offers a comprehensive range of tests, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology.
Key Points:
- Range of Tests:
- Biochemistry Tests
- Immunology Tests
- Hematology Tests
- Molecular Biology Tests
- Serology Tests
- Microbiology Tests
- Histopathology Tests
- Patient and Test Volume: In FY 2024, the company served 95,946 patients and conducted 344,467 tests.
- Customer Segments:
- B2B (Hospitals and Contract Research Organizations): ₹ 1.30 crore (20.33%) in FY 2024.
- B2C (Individual walk-in customers): ₹ 5.10 crore (79.67%) in FY 2024.
Competitive Strengths:
- NABL Accreditation:
- Certification ensures high quality of services, fostering customer confidence.
- Chain of Diagnostic Centers:
- Eight centers across Thane, Raigad, and Navi Mumbai, providing accessible services.
- Established trust with customers over 30+ years.
- Experienced Promoters and Management:
- Promoters Jagdish Umakant Nayak and Jyoti Jagdish Nayak have over 30 years of experience.
- Experienced senior management team with expertise in technical, customer relationship, operational, marketing, and business development.
- Strong Customer Relationships:
- Long-standing relationships with customers, leading to repeat business and cross-selling opportunities.
- Aim to be the "first choice service provider" for diagnostic services.
Objects of the Issue
- Expansion of Diagnostic Centres
- General corporate purposes
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 25 Jul - 29 Jul 2024 |
| IPO Price Band | ₹ 96 per share |
| Fresh Issue | 6,02,400 shares |
| Offer For Sale | NIL |
| Total IPO Size | ₹ 5.78 crore |
| Face Value | ₹ 10 |
| Listing On | BSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 25 Jul 2024 |
| IPO Closing Date | 29 Jul 2024 |
| Basis Of Allotment | 30 Jul 2024 |
| Refunds | 31 Jul 2024 |
| Demat Transfer | 31 Jul 2024 |
| IPO Listing Date | 01 Aug 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | 31st March 2024 |
|---|---|---|---|---|
| Total Income | 4.60 | 6.46 | 6.36 | 6.44 |
| Total Expenses | 3.73 | 5.32 | 5.00 | 5.42 |
| Net Profit/Loss | 0.40 | 0.51 | 0.61 | 0.37 |
| NPM (*) | 8.75 | 7.94 | 9.63 | 5.76 |
| Total Assets | 2.73 | 3.69 | 6.03 | 5.61 |
| Total Liabilities | 1.34 | 1.84 | 3.65 | 2.06 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2022 | 31st March 2024 |
|---|---|---|---|---|
| EPS | 6.04 | 3.42 | 4.09 | 2.37 |
| ROE (%) | 27.0 | 25.0 | 25.0 | 10.0 |
| ROCE (%) | 24.0 | 24.0 | 25.0 | 12.0 |
| D/E Ratio | 0.32 | 0.40 | 0.41 | 0.24 |
| Current Ratio | 2.19 | 1.05 | 1.20 | 1.66 |
| EBITDA MARGIN (%) | 18.85 | 17.64 | 21.53 | 15.87 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | Revenue | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|---|
| Clinitech Laboratory | 6.44 | 40.51 | 2.37 | 10.46 | 21.12 |
| Dr Lalpath Labs | 2,295.81 | 67.92 | 43.05 | 19.19 | 225.85 |
| Thyrocare | 581.25 | 47.56 | 13.42 | 13.17 | 99.65 |
| Krsnaa Diagnostics | 636.43 | 38.42 | 17.90 | 7.02 | 250.79 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 0 |
| Non-Institutional Investor (NII/HNI) | 23.28 |
| Retail Individual Investor (RII) | 49.61 |
| Total | 38.96 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
Bigshare Services Private Limited
Phone: +91 22-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Company Promoters
- JAGDISH UMAKANT NAYAK
- JYOTI JAGDISH NAYAK
- ASHUTOSH JAGDISH NAYAK
Lead Managers
- INVENTURE MERCHANT BANKER SERVICES PRIVATE LIMITED
Company Address
Clinitech Laboratory Limited
AL-1/545, Sector 16, Airoli, Opposite Radhikabai Meghe Vidyalaya, Navi Mumbai, Thane - 400708, Maharashtra, India
Phone: +91 22 45003240/ +91 9004072223
Email: ipo@clinitechlab.com
Website: www.ctllab.in
FAQs
- What is the issue size of the Clinitech Laboratory SME IPO?The Clinitech Laboratory SME IPO has an issue size of ₹ 5.78 crore. This includes a fresh issue of 6,02,400 shares and an offer for sale (OFS) of NIL.
- What is the price band of the Clinitech Laboratory IPO?The price band for the Clinitech Laboratory IPO is ₹ 96 per share.
- What are the bidding dates for the Clinitech Laboratory IPO?The Clinitech Laboratory IPO will open for bidding on 25 Jul 2024 and close on 29 Jul 2024.
- What is the allotment date for the Clinitech Laboratory IPO?The allotment date for the Clinitech Laboratory IPO is 30 Jul 2024.
- What is the listing date for the Clinitech Laboratory IPO?The listing date for the Clinitech Laboratory IPO is 01 Aug 2024.
- What is the Clinitech Laboratory IPO grey market premium?The grey market premium (GMP) for the Clinitech Laboratory IPO is currently at ₹65, with an expected listing gain of approximately 67.71%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.